Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Chinese subpopulation analysis of a double-blind, randomized, placebo-controlled study
Gang Wang,1–3 Yan Cheng,4 Jia Ning Wang,4 Sheng Hu Wu4 Hai Bo Xue5 1Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, Beijing, People’s Republic of China; 2China Clinical Research Center for Mental Disorders, Beijing, People’s Republic of Chin...
Guardado en:
Autores principales: | Wang G, Cheng Y, Wang JN, Wu SH, Xue HB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60aabce15e8744359ce9f76804d52041 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of olanzapine/fluoxetine combination in the treatment of treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Luan S, et al.
Publicado: (2017) -
Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
por: Maneeton B, et al.
Publicado: (2017) -
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
por: Katagiri H, et al.
Publicado: (2018) -
Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
por: Yalin N, et al.
Publicado: (2020) -
Psychometric Properties of the Chinese Version of the Bipolar Depression Rating Scale for Bipolar Disorder
por: Chen JX, et al.
Publicado: (2021)